These observations fit with the more recent data from Ten Brinck et al., who reported that ACPA levels were not associated with higher hazards for progression to clinical arthritis in 241 patients with clinically suspect arthralgia [29]. This evidence concerns the gene PRTN3 and arthritic joint disease.